carbostyril has been researched along with Bipolar Disorder in 206 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 102 (49.51) | 29.6817 |
| 2010's | 102 (49.51) | 24.3611 |
| 2020's | 2 (0.97) | 2.80 |
| Authors | Studies |
|---|---|
| Brewer, C; Chang, D; Hefting, N; Hellsten, J; Peters-Strickland, T; Sachs, G; Vieta, E | 1 |
| Arıkan, MK; Günver, G; İlhan, R; Metin, B; Öksüz, Ö | 1 |
| Lambrichts, S; Sienaert, P; Van Oudenhove, L | 1 |
| Cope, ZA; Geyer, MA; Hellemann, G; Kwiatkowski, MA; Minassian, A; Perry, W; Sugar, CA; Young, JW | 1 |
| Brown, ES; Escalante, C; Holmes, T; Ivleva, E; Khaleghi, N; Mason, BL; Nakamura, A; Van Enkevort, E | 1 |
| Chen, MH; Liou, YJ | 1 |
| Carlson, GA; Carson, WH; Correll, CU; Findling, RL; Forbes, RA; Ivanova, S; Jin, N; Mankoski, R; McQuade, RD; Nyilas, M | 1 |
| DelBello, MP; Welge, JA | 1 |
| Emslie, GJ | 1 |
| Carson, W; Findling, RL; Forbes, RA; Mankoski, R; Marcus, RM; McQuade, R; Youngstrom, E; Zhao, J | 1 |
| Dell'Osso, L; Marazziti, D; Moroni, I; Piccinni, A; Veltri, A | 1 |
| Caccia, F; Caloro, M; Cuomo, I; De Filippis, S; De Persis, S; Gentile, G; Girardi, P; Janiri, D; Kotzalidis, GD; Lionetto, L; Piazzi, G; Sciarretta, A; Simmaco, M; Simonetti, A; Telesforo, CL | 1 |
| De Berardis, D; Di Giannantonio, M; Martinotti, G; Moschetta, FS; Serroni, N | 1 |
| Bio, DS; Costa, LF; David, DP; Demétrio, FN; Fernandes, F; Missio, G; Moreno, DH; Moreno, RA; Rodrigues dos Santos, D; Soeiro-de-Souza, MG | 1 |
| Coley, KC; Fabian, TJ; Haskett, R; Kreys, TJ; Saul, MI | 1 |
| Altamura, AC; Buoli, M; Serati, M | 1 |
| Kearns, B; Ren, S; Stevenson, M; Uttley, L | 1 |
| Dore, J; Hill, SJ; Hooshmand, F; Ketter, TA; Miller, S; Portillo, N; Wang, PW | 1 |
| Allain-Veyrac, G; Gaboriau, L; Gérardin, M; Grall-Bronnec, M; Jolliet-Evin, P; Victorri-Vigneau, C | 1 |
| Brown, R; Geddes, J; Taylor, MJ | 1 |
| McKeage, K | 1 |
| Belletti, A; Cilia, R; Marotta, G; Pezzoli, G; Siri, C | 1 |
| Chennoufi, L; Cheour, M; Ouanes, S | 1 |
| Eryilmaz, G; Gül, IG; Hizli Sayar, G; Karamustafalioğlu, O; Özten, E; Yorbik, Ö | 1 |
| Arunagiri, P; Balamurugan, E; Rajeshwaran, K; Shanthakumar, J; Tamilselvan, T | 1 |
| Lu, CL; Shen, YC | 1 |
| Chan, HY; Tan, HK; Wu, WY | 1 |
| Cornelius, V; Smith, L; Taylor, DM; Young, AH | 1 |
| Carta, MG; Moro, MF | 1 |
| Malempati, RN | 1 |
| Abrial, E; Bétourné, A; Etiévant, A; Haddjeri, N; Lambás-Señas, L; Lucas, G; Scarna, H | 1 |
| Brugnoli, R; De Filippis, S; Di Sciascio, G; Fagiolini, A; Maina, G | 1 |
| Arao, T; Kuno, F; Kurozumi, A; Okada, Y; Tanaka, Y | 1 |
| Bilgiç, A; Yılmaz, E; Yılmaz, S | 1 |
| Citrome, L | 1 |
| Badran, IA; Correll, CU; Curran, RL; DelBello, MP; Pedapati, EV; Peppers, V | 1 |
| Arnt, J; Geyer, MA; Milienne-Petiot, M; Young, JW | 1 |
| Chang, KD | 1 |
| Nelson, R; Pumariega, AJ; Rotenberg, L | 1 |
| Croarkin, PE; Emslie, GJ; Mayes, TL | 1 |
| Boulton, DW; Carson, WH; Findling, RL; Forbes, RA; Kauffman, RE; Mallikaarjun, S; Nyilas, M; Pikalov, A; Sallee, FR; Shoaf, SE | 1 |
| Carlson, BX; Eudicone, J; Marcus, RN; Masand, PS; McQuade, RD; Pikalov, A; Vester-Blokland, E | 1 |
| Rybakowski, JK | 1 |
| Fagiolini, A | 1 |
| Arsura, E; Sethi, NK; Torgovnick, J | 1 |
| Calabrese, JR; Kemp, DE | 1 |
| Carson, WH; Cutler, AJ; Keck, PE; Marcus, RN; McQuade, RD; Orsulak, PJ; Sanchez, R; Torbeyns, A | 1 |
| Bria, P; Janiri, L; Mazza, M; Pecora, RD; Squillacioti, MR | 2 |
| Aitchison, KJ; Bienroth, M; Cookson, J; Goodwin, GM; Gray, R; Haddad, PM; Moore, B; Ratna, L; Sullivan, G; Taylor, D; Taylor, M | 1 |
| Ammerman, DK; Coley, KC; Fabian, TJ; Ganguli, R; Kim, E; Kim, MS; Saul, MI; Scipio, TM; Whitehead, R | 1 |
| Carson, WH; Lowy, A; Marcus, RN; McQuade, RD; Oren, DA; Sanchez, R; Spiller, NH; Torbeyns, AF; Young, AH | 1 |
| Balch, AH; Benson, J; Boulton, DW; Carlson, BX; Croop, R; Mallikaarjun, S; Schieber, FC | 1 |
| Jana, AK; Praharaj, SK; Sinha, VK | 1 |
| Khalid, I; Khalid, TJ; Rana, L; Roehrs, T | 1 |
| Coley, KC; Fabian, TJ; Lenze, EJ; Ruby, C; Scipio, TM | 1 |
| Smith, EJ | 1 |
| Ketzer, CR; Narvaez, J; Pheula, GF; Rohde, LA; Tramontina, S; Zeni, CP | 1 |
| Arvilommi, P; Isometsä, E; Leppämäki, S; Mantere, O; Suominen, K; Valtonen, HM | 1 |
| Jing, Y; Kim, E; Pikalov, A; Tran, QV; You, M | 1 |
| Cruz, N; Goikolea, JM; Sanchez-Moreno, J; Torres, F; Valentí, M; Vieta, E | 1 |
| De León, OA; Garza, VM; Shepherd, J | 1 |
| Ketzer, CR; Pheula, GF; Rohde, LA; Tramontina, S; Zeni, CP | 1 |
| Wagner, KD | 1 |
| Carson, WH; Chang, K; Findling, RL; Forbes, RA; Ivanova, S; Iwamoto, T; Jin, N; McQuade, RD; Nyilas, M | 1 |
| Leckband, SG; Meyer, JM; Strack, DK | 1 |
| Carbray, MJ; McGuinness, T | 1 |
| Assunção-Talbott, S; Barnes, TR; Buckley, P; Correll, CU; Eudicone, J; Kane, JM; McQuade, R; Pikalov, A; Sachs, G; Tran, QV | 1 |
| Mavrikaki, M; Nomikos, GG; Panagis, G | 1 |
| Barnett, RJ; Cauble, S; McLaren, JL | 1 |
| Chen, ST; Hsiao, YL | 1 |
| McIntyre, RS | 1 |
| Chou, JC | 1 |
| Anghelescu, I; Born, C; Langosch, J; Luborzewski, A; Quante, A; Schommer, N; Wolf, J; Zeugmann, S | 1 |
| Barth, KS; Garner, A; Phan, SV; Snarr, BS; VandenBerg, AM | 1 |
| Deng, C; Huang, XF; Lian, J; Pai, N | 1 |
| Baudelet, C; Marcus, RN; McQuade, RD; Owen, R; Sanchez, R; Vieta, E | 1 |
| Baker, RA; Calabrese, JR; Eudicone, JM; Kemp, DE; Pikalov, A; Tran, QV | 1 |
| Kovács, G | 1 |
| Lazarus, A; Quon, P; Tafesse, E; Woodward, TC | 1 |
| Carson, WH; El Mallakh, RS; Marcus, R; McQuade, R; Rollin, L; Vieta, E | 1 |
| Baker, RA; Chambers, JS; Eudicone, JM; Kemp, DE; McQuade, RD | 1 |
| De Fazio, P; Girardi, P; Maina, G; Mauri, M; Mauri, MC; Monteleone, P; Perini, GI; Perugi, G; Rossi, A | 1 |
| Carson, W; Cziraky, MJ; Delorenze, G; Niemcryk, SJ; Oliveria, SA; Phillips, S; Quesenberry, CP; Skovron, ML; Tsai, AL; Ulcickas Yood, M; Wells, K; Willey, VJ | 1 |
| Fountoulakis, KN; Schmidt, F; Vieta, E | 1 |
| Calabrese, JR; Carlson, BX; Eudicone, JM; Ganocy, S; Kemp, DE; Marcus, RN; McQuade, RD; Owen, R; Tran, QV; Vester-Blokland, E | 1 |
| Brecher, M; Calabrese, JR; Carlson, BX; Edwards, S; Eudicone, JM; Evoniuk, G; Ganocy, SJ; Jansen, W; Kemp, DE; Leon, AC; Minkwitz, M; Pikalov, A; Stassen, HH; Szegedi, A; Tohen, M; Van Willigenburg, AP | 1 |
| Leinonen, E; Valtonen, HM; Viikki, M | 1 |
| Albayrak, Y; Caykoylu, A; Ekinci, O; Ugurlu, GK | 1 |
| Katzman, MA | 1 |
| Yatham, LN | 1 |
| Casamassima, F; Fagiolini, A; Forgione, RN; Marra, FS; Nitti, M | 1 |
| Carson, W; Khan, A; Marcus, R; Morris, B; Rollin, L; Sanchez, R; Timko, K | 1 |
| Andel, R; Becker, MA; Boaz, TL; Chandler, K; Desmarais, SL; Howe, A; Van Dorn, RA | 1 |
| Bouckaert, F; De Schutter, P; Peuskens, J | 1 |
| Healy, D; Jureidini, JN; Parry, PI; Rosenlicht, NZ; Spielmans, GI; Tsai, AC | 1 |
| Eriksson, J; Kasteng, F; Lindgren, P; Sennfält, K | 1 |
| Carson, WH; Forbes, RA; Mankoski, R; Mathew, SJ; Zhao, J | 1 |
| Calabrese, JR; Demeter, CA; Findling, RL; Frazier, TW; Lingler, J; McNamara, NK; Otto, BD; Rowles, BM; Stansbrey, RJ; Youngstrom, EA | 1 |
| Bauer, LK; Januzzi, JL; Leskov, I; Mukherji, EH; Tanev, KS | 1 |
| Diaz-Atienza, F; Gurpegui, M; Gutiérrez-Rojas, L; Jurado, D; Martínez-Ortega, JM | 1 |
| Bastiampillai, T; Dhillon, R; Goh, T | 1 |
| Abbar, M; Ågren, H; Altamura, AC; Bellivier, F; Fountoulakis, KN; Goodwin, GM; Grunze, H; Holsboer-Trachsler, E; Licht, RW; Pitchot, W; Schlaepfer, TE; Vieta, E | 1 |
| Ahn, YM; Bahk, WM; Chung, MY; Chung, SK; Kim, DH; Kim, JG; Lee, JH; Lee, KH; Paik, KC; Woo, YS; Yoon, BH | 1 |
| Karadağ, F; Tan, D; Unal, F | 1 |
| Adegbite, C; Calabrese, JR; Demeter, CA; Findling, RL; Frazier, TW; McNamara, NK; Rowles, BM; Stansbrey, RJ; Wynbrandt, JL; Youngstrom, EA | 1 |
| Chen, CK; Chou, MC; Chou, WJ; Huang, YS; Tang, CS; Wang, LJ; Yeh, CB | 1 |
| Dhillon, S | 1 |
| Baudelet, C; Carson, WH; El-Mallakh, RS; Marcus, R; McQuade, R; Owen, R | 1 |
| Brotzge, K; El-Mallakh, RS; Manshadi, M | 1 |
| Bobo, WV; Chen, Y; Jayathilake, K; Meltzer, HY; Tang, T; Watts, K | 1 |
| Bowden, CL; Carlson, BX; Eudicone, JM; Marcus, R; McQuade, RD; Nashat, M; Thase, ME | 1 |
| Carlson, BX; Ketter, TA; Marcus, R; McQuade, RD; Sanchez, R; Sun, W; Timko, K; Vester-Blokland, E | 1 |
| Doey, T | 1 |
| Kirino, E | 1 |
| Cottencin, O; Geoffroy, PA; Goddefroy, G; Rolland, B | 1 |
| Ishigooka, J; Kanba, S; Kawasaki, H; Kinoshita, T; Kuroki, T; Sakamoto, K | 1 |
| Khemiri, L; Moreira, T; Runeson, L | 1 |
| Magno Zito, J; Safer, AM; Safer, DJ | 1 |
| Isogai, S; Kasai, E; Mori, N; Morimoto, S; Nakasato, K; Suzuki, K; Takagai, S | 1 |
| Bobmanuel, S; Davies, W; Dratcu, L; Farmer, A; George, M; Rana, T; Singh, M; Turner, M | 1 |
| Bradshaw, B; Henry, J; Macedo, LR; Marino, J | 1 |
| Alvir, JM; Berger, A; Edelsberg, J; Mychaskiw, MA; Oster, G; Sanders, KN | 1 |
| de Bartolomeis, A; Perugi, G | 1 |
| Bauer, MS; Kilbourne, AM; Lai, Z; Mohr, DC; Penfold, RB; Seibert, MN | 1 |
| Andersson, C; Findling, RL; Mankoski, R; Marcus, R; McQuade, R; Youngstrom, EA; Zhao, J | 1 |
| Capapey, J; Colom, F; Goikolea, JM; Grande, I; Sanchez-Moreno, J; Torres, I; Undurraga, J; Valentí, M; Vieta, E | 1 |
| Lin, CC; Lin, HY; Liu, CC | 1 |
| Aulisa, AG; Bocchino, L; Marzetti, E; Scudieri, G; Teramo, S | 1 |
| Baker, RA; Carlson, BX; De Hert, M; Eudicone, JM; Fyans, P; Kemp, DE; Marler, SV; Rahman, Z | 1 |
| Ammerman, D; Baker, RA; Carlson, BX; Fountoulakis, KN; Fyans, P; Marler, SV; Rahman, Z; Yatham, LN | 1 |
| Bienroth, M; Curtis, V; Debenham, M; George, M; Gonzalez, D; Jones, S; Pitsi, D | 1 |
| Almeida, JR; Axelson, DA; Birmaher, B; Diler, RS; Ladouceur, CD; Pan, LA; Phillips, ML; Segreti, A | 1 |
| Goodnick, PJ; Jerry, JM | 1 |
| Ali, M; Ingenito, G; Keck, PE; Liebeskind, A; Marcus, R; Saha, A; Tourkodimitris, S | 1 |
| Green, B | 1 |
| Lyseng-Williamson, KA; Perry, CM | 1 |
| Crismon, ML; DeLeon, A; Patel, NC | 1 |
| Davids, E; Fischer, B; Gastpar, M | 1 |
| Bowers, MB; Cooper, C; Lim, S; Pralea, C; Schnitt, J | 1 |
| Andrade, C | 1 |
| Jagadheesan, K; Muirhead, D | 1 |
| Durkin, JP | 1 |
| Barzman, DH; Campbell, P; DelBello, MP; Delgado, SV; Fleck, DE; Gernert, B; Kowatch, RA; Pathak, S; Rappaport, K; Strakowski, SM | 1 |
| Aleardi, M; Biederman, J; Falzone, R; McDonnell, MA; Mick, E; Spencer, T; Wozniak, J | 1 |
| Errico, JR; Yates, WR | 1 |
| Keck, PE | 1 |
| Vieta, E | 1 |
| Winter, AS; Witschy, JK | 1 |
| Kinghorn, WA; McEvoy, JP | 1 |
| Beard, L; Brown, ES; Garza, M; Jeffress, J; Liggin, JD | 1 |
| Tsai, SJ | 1 |
| Baldessarini, RJ; Centorrino, F; Cimbolli, P; Cincotta, SL; Fogarty, KV; Salvatore, P; Sani, G; Thompson, TA | 1 |
| Berk, M; Bourin, M; Dodd, S; Ivanovski, B; Lagopoulos, J; Malhi, GS; Mitchell, PB | 1 |
| Abou-Gharbia, N; Bourin, M; Carson, W; Iwamoto, T; Marcus, R; McQuade, R; Sanchez, R; Stock, E; Swanink, R; Vieta, E | 1 |
| Janvier, YM; Rugino, TA | 1 |
| Fleischhacker, WW | 1 |
| Bennett, N; Hirsch, J; Kafantaris, V; Saito, E | 1 |
| Basson, BR; Treuer, T | 1 |
| Barnas, ME; Hussain, N; Petrides, G | 1 |
| Murphy, TK; Negin, B | 1 |
| Hatchett, AD; Zacher, JL | 1 |
| Abou-Gharbia, N; Carson, W; Impellizzeri, C; Iwamoto, T; Kaplita, S; Marcus, R; McQuade, R; Rollin, L; Sachs, G; Sanchez, R; Stock, E | 1 |
| Raja, M | 1 |
| Calabrese, JR; Carlson, BX; Carson, WH; Keck, PE; Marcus, RN; McQuade, RD; Rollin, LM; Sanchez, R | 1 |
| Desarkar, P; Sinha, VK; Thakur, A | 1 |
| Lacasse, JR; Leo, J | 1 |
| Ali, S; Patel, P; Pearlman, RL; Upadhyay, A | 1 |
| Cipriani, A; Geddes, JR; Rendell, JM | 1 |
| Ehret, MJ; Levin, GM | 1 |
| Coffey, B; Jummani, R; Vito, J | 1 |
| Chou, JC; Fazzio, L | 1 |
| Correll, CU; Frederickson, AM; Kane, JM; Manu, P | 1 |
| Sokolski, KN | 1 |
| Padala, PR; Petty, F; Wengel, SP | 1 |
| Altshuler, LL; Frye, MA; Keck, PE; Leverich, GS; Martens, B; McElroy, SL; Post, RM; Stanford, K; Suppes, T | 1 |
| Dago, PL; Fleck, J; Gilmer, WS; Karaffa, M; Kemp, DE; Straus, JL | 2 |
| Adler, CM; DelBello, MP; Singh, MK | 1 |
| Modestin, J; Schneiter, R; Traber, R | 1 |
| Auby, P; Manos, G; Marcus, RN; McQuade, RD; Oren, DA; Stock, E; Zimbroff, DL | 1 |
| Baghai, TC; Born, C; Eser, D; Häfner, S; Hecht, S; Hermisson, I; Nothdurfter, C; Rupprecht, R; Schüle, C | 1 |
| Konarski, JZ; McIntyre, RS; Miranda, A; Soczynska, JK; Woldeyohannes, HO | 1 |
| Behere, RV; Gangadhar, BN; Naveen, MN; Venkatasubramanian, G | 1 |
| Citrome, LL; Crandall, DT; Currier, GW; Manos, G; McQuade, R; Oren, D; Pikalov, AA; Zimbroff, DL | 1 |
| Sahoo, S | 1 |
| Konarski, JZ; McIntyre, RS; Miranda, A; Soczynska, JK; Woldeyohannes, HO; Yasgur, BS | 1 |
| Constant, EL; Emmanuel, H; Hermans, E; Jean-Jean, A; Koener, B; Maloteaux, JM | 1 |
| Aleardi, M; Biederman, J; Doyle, R; Hammerness, P; Joshi, G; Kotarski, M; Mick, E; Spencer, T; Wozniak, J | 1 |
| Lorenz, RA; Weinstein, B | 1 |
| Carlson, B; Eudicone, J; McQuade, R; Pikalov, A; Suppes, T | 1 |
| Crandall, DT; Gaulin, BD; Gutierrez-Esteinou, R; Marcus, RN; McQuade, RD; Pikalov, A; Pultz, JA; Sachs, GS; Sanchez, R | 1 |
| de Souza, CK; Pheula, GF; Rohde, LA; Tramontina, S; Zeni, CP | 1 |
| Jain, R; Skale, TG | 1 |
| Calabrese, JR; Carlson, BX; Carson, WH; Eudicone, JM; Keck, PE; Marcus, RN; McIntyre, RS; McQuade, RD; Sanchez, R | 1 |
| Perlis, RH | 1 |
| Bowden, CL; Carson, WH; Jonas, A; Khan, A; Marcus, RN; McQuade, RD; Owen, R; Thase, ME; Wu, X | 1 |
| Calabrese, JR; Gajwani, P; Ganocy, SJ; Gao, K; Kemp, DE; Muzina, DJ | 1 |
| Chriki, LS; Dunn, RT; Filkowski, MM; Ghaemi, SN; Stan, VA | 1 |
| Blow, FC; Cassidy, KA; Coconcea, N; Hays, RW; Ignacio, RV; Meyer, WJ; Sajatovic, M | 1 |
| Sanford, M; Scott, LJ | 1 |
| Gregoriou, S; Karagiorga, T; Kontochristopoulos, G; Rigopoulos, D; Stratigos, A; Volonakis, K | 1 |
| Carlson, BX; Eudicone, J; Frye, MA; Marcus, RN; McQuade, RD; Pikalov, A | 1 |
| Lo, B; Pizon, A | 1 |
| Carlson, BX; Eudicone, JM; Marcus, RN; McQuade, RD; Momah, C; Muzina, DJ; Pikalov, A; Sanchez, R | 1 |
48 review(s) available for carbostyril and Bipolar Disorder
| Article | Year |
|---|---|
Antibiotics and mania: A systematic review.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bipolar Disorder; Child; Child, Preschool; Female; Humans; Macrolides; Male; Middle Aged; Quinolones; Young Adult | 2017 |
Dopamine transporter knockdown mice in the behavioral pattern monitor: A robust, reproducible model for mania-relevant behaviors.
Topics: alpha-Methyltyrosine; Animals; Antimanic Agents; Behavior, Animal; Bipolar Disorder; Cohort Studies; Disease Models, Animal; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Enzyme Inhibitors; Exploratory Behavior; Gene Knockdown Techniques; Locomotion; Mice; Mice, Inbred C57BL; Quinolones; Reproducibility of Results; Thiophenes; Tyrosine 3-Monooxygenase; Valproic Acid | 2019 |
Is the combination of a mood stabilizer plus an antipsychotic more effective than mono-therapies in long-term treatment of bipolar disorder? A systematic review.
Topics: Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Drug Therapy, Combination; Humans; Long-Term Care; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Thiazoles; Treatment Outcome | 2014 |
Aripiprazole for the treatment and prevention of acute manic and mixed episodes in bipolar I disorder in children and adolescents: a NICE single technology appraisal.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Child; Clinical Trials as Topic; Cost-Benefit Analysis; Humans; Piperazines; Precision Medicine; Quinolones | 2013 |
Aripiprazole alone or in combination for acute mania.
Topics: Adolescent; Adult; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Child; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Haloperidol; Humans; Lithium Compounds; Piperazines; Quinolones; Randomized Controlled Trials as Topic; Valproic Acid | 2013 |
Aripiprazole: a review of its use in the treatment of manic episodes in adolescents with bipolar I disorder.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Clinical Trials, Phase III as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; European Union; Humans; Medication Adherence; Piperazines; Psychiatric Status Rating Scales; Quinolones; Randomized Controlled Trials as Topic | 2014 |
An update on the treatment of mixed bipolar states: what is new in 2013?
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Calcitonin; Dibenzocycloheptenes; Heterocyclic Compounds, 4 or More Rings; Humans; Olanzapine; Piperazines; Quinolones; Randomized Controlled Trials as Topic; Thiazoles; Treatment Outcome | 2014 |
Comparative efficacy and acceptability of drug treatments for bipolar depression: a multiple-treatments meta-analysis.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Depression; Dibenzothiazepines; Drug Therapy, Combination; Fluoxetine; Humans; Isoindoles; Lamotrigine; Lithium Compounds; Lurasidone Hydrochloride; Monoamine Oxidase Inhibitors; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Selective Serotonin Reuptake Inhibitors; Thiazoles; Treatment Outcome; Triazines; Valproic Acid | 2014 |
Evaluating aripiprazole as a potential bipolar disorder therapy for adults.
Topics: Adult; Animals; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Humans; Piperazines; Quinolones; Treatment Outcome | 2014 |
The use of atypical antipsychotics in pediatric bipolar disorder.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Attention Deficit and Disruptive Behavior Disorders; Bipolar Disorder; Child; Comorbidity; Dibenzothiazepines; Disorders of Excessive Somnolence; Humans; Obesity; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Thiazoles; Weight Gain | 2008 |
Neuroleptic malignant syndrome associated with atypical antipsychotics in pediatric patients: a review of published cases.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Child; Child, Preschool; Clozapine; Dibenzothiazepines; Humans; Neuroleptic Malignant Syndrome; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Retrospective Studies; Risperidone; Thiazoles | 2008 |
Efficacy of modern antipsychotics in placebo-controlled trials in bipolar depression: a meta-analysis.
Topics: Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Drug Combinations; Drug Therapy, Combination; Fluoxetine; Humans; Olanzapine; Piperazines; Placebos; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Treatment Outcome | 2010 |
Evaluation of akathisia in patients with schizophrenia, schizoaffective disorder, or bipolar I disorder: a post hoc analysis of pooled data from short- and long-term aripiprazole trials.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Double-Blind Method; Haloperidol; Humans; Hypnotics and Sedatives; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Psychomotor Agitation; Psychotic Disorders; Quinolones; Randomized Controlled Trials as Topic; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2010 |
Aripiprazole for the maintenance treatment of bipolar I disorder: A review.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Double-Blind Method; Humans; Lithium; Metabolic Diseases; Obesity; Piperazines; Quinolones; Randomized Controlled Trials as Topic; Secondary Prevention; Treatment Outcome | 2010 |
Mixed episodes with psychotic features.
Topics: Acute Disease; Adult; Affect; Anticonvulsants; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Therapy, Combination; Evidence-Based Medicine; Hospitalization; Humans; Male; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Treatment Outcome; Valproic Acid | 2009 |
Aripiprazole in acute mania and long-term treatment of bipolar disorder: a critical review by an Italian working group.
Topics: Antimanic Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Drug Administration Schedule; Drug Therapy, Combination; Evidence-Based Medicine; Humans; Italy; Medication Adherence; Piperazines; Quinolones; Time Factors; Treatment Outcome | 2010 |
Aripiprazole monotherapy in the treatment of bipolar disorder: a meta-analysis.
Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Depression; Humans; Piperazines; Quinolones; Randomized Controlled Trials as Topic; Treatment Outcome | 2011 |
Predictive value of early improvement in bipolar depression trials: a post-hoc pooled analysis of two 8-week aripiprazole studies.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Double-Blind Method; Drug Resistance; Female; Humans; Linear Models; Logistic Models; Male; Middle Aged; Multicenter Studies as Topic; Piperazines; Predictive Value of Tests; Psychiatric Status Rating Scales; Quinolones; Randomized Controlled Trials as Topic; Remission Induction; Sensitivity and Specificity; Time Factors; Treatment Outcome | 2010 |
Aripiprazole: a clinical review of its use for the treatment of anxiety disorders and anxiety as a comorbidity in mental illness.
Topics: Anti-Anxiety Agents; Antipsychotic Agents; Anxiety; Anxiety Disorders; Aripiprazole; Bipolar Disorder; Depressive Disorder, Major; Drug Therapy, Combination; Humans; Mental Disorders; Piperazines; Quinolones | 2011 |
A clinical review of aripiprazole in bipolar depression and maintenance therapy of bipolar disorder.
Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Drug Therapy, Combination; Humans; Lithium Compounds; Piperazines; Quinolones; Secondary Prevention | 2011 |
Aripiprazole for the treatment of bipolar disorder: a review of current evidence.
Topics: Administration, Oral; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Injections, Intramuscular; Piperazines; Quinolones | 2011 |
Aripiprazole in the maintenance treatment of bipolar disorder: a critical review of the evidence and its dissemination into the scientific literature.
Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Evidence-Based Medicine; Humans; Lithium; Piperazines; Quinolones; Randomized Controlled Trials as Topic; Secondary Prevention; Treatment Outcome | 2011 |
Aripiprazole in patients with bipolar mania and beyond: an update of practical guidance.
Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Female; Humans; Hypnotics and Sedatives; Male; Piperazines; Practice Guidelines as Topic; Quinolones | 2011 |
Aripiprazole: a review of its use in the management of mania in adults with bipolar I disorder.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Humans; Piperazines; Psychiatric Status Rating Scales; Quinolones; Randomized Controlled Trials as Topic; Treatment Outcome | 2012 |
Aripiprazole in bipolar depression: a pooled, post-hoc analysis by severity of core depressive symptoms.
Topics: Adolescent; Adult; Aged; Akathisia, Drug-Induced; Analysis of Variance; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Body Weight; Depression; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Nausea; Piperazines; Quinolones; Randomized Controlled Trials as Topic; Treatment Outcome; Young Adult | 2012 |
Aripiprazole in pediatric psychosis and bipolar disorder: a clinical review.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Child; Humans; Piperazines; Psychotic Disorders; Quinolones; Schizophrenia | 2012 |
Efficacy and safety of aripiprazole in child and adolescent patients.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Autistic Disorder; Bipolar Disorder; Child; Humans; Piperazines; Quinolones; Schizophrenia | 2012 |
Age-grouped differences in bipolar mania.
Topics: Adolescent; Adult; Age Factors; Aggression; Anger; Antipsychotic Agents; Aripiprazole; Attention Deficit and Disruptive Behavior Disorders; Benzodiazepines; Bipolar Disorder; Child; Clinical Trials as Topic; Comorbidity; Defense Mechanisms; Female; Humans; Irritable Mood; Male; Middle Aged; Motor Activity; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Psychometrics; Quinolones; Sexual Behavior; Thinking; Young Adult | 2012 |
Combination of aripiprazole with mood stabilizers for the treatment of bipolar disorder: from acute mania to long-term maintenance.
Topics: Affect; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Drug Therapy, Combination; Humans; Lithium Compounds; Piperazines; Quinolones; Valproic Acid | 2012 |
Lower rate of depressive switch following antimanic treatment with second-generation antipsychotics versus haloperidol.
Topics: Acute Disease; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Depression; Depressive Disorder; Dibenzothiazepines; Double-Blind Method; Drug Industry; Haloperidol; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Research Support as Topic; Risperidone; Thiazoles | 2013 |
Aripiprazole: profile on efficacy and safety.
Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Brain; Cardiovascular System; Clinical Trials as Topic; Digestive System; Dyskinesia, Drug-Induced; Humans; Mental Disorders; Piperazines; Quinolones; Schizophrenia | 2002 |
Focus on aripiprazole.
Topics: Alzheimer Disease; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Drug Interactions; Humans; Piperazines; Psychotic Disorders; Quinolones; Schizophrenia | 2004 |
Aripiprazole: in acute mania associated with bipolar I disorder.
Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Evaluation; Drug Tolerance; Humans; Piperazines; Practice Guidelines as Topic; Quinolones | 2004 |
Aripiprazole: a comprehensive review of its pharmacology, clinical efficacy, and tolerability.
Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Humans; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Quinolones; Randomized Controlled Trials as Topic; Schizophrenia | 2004 |
[Aripiprazole: a new atypical antipsychotic drug].
Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Humans; Piperazines; Psychotic Disorders; Quinolones; Randomized Controlled Trials as Topic | 2004 |
The role of second-generation antipsychotic monotherapy in the rapid control of acute bipolar mania.
Topics: Acute Disease; Anticonvulsants; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Benzodiazepines; Bipolar Disorder; Clozapine; Dibenzothiazepines; Double-Blind Method; Humans; Lithium; Olanzapine; Piperazines; Placebos; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Treatment Outcome | 2005 |
The treatment of mixed states and the risk of switching to depression.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Electroconvulsive Therapy; Haloperidol; Health Education; Humans; Lithium Carbonate; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Thiazoles | 2005 |
Aripiprazole: pharmacology, efficacy, safety and tolerability.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Humans; Piperazines; Quinolones; Schizophrenia | 2005 |
A typical mood stabilizers: a "typical role for atypical antipsychotics.
Topics: Affect; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Clozapine; Dibenzothiazepines; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Secondary Prevention; Sulpiride; Thiazoles | 2005 |
Aripiprazole.
Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Humans; Piperazines; Quinolones; Schizophrenia; Schizophrenic Psychology | 2005 |
Haloperidol alone or in combination for acute mania.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Carbamazepine; Dibenzothiazepines; Drug Therapy, Combination; Haloperidol; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Sulpiride; Valproic Acid | 2006 |
Long-term use of atypical antipsychotics in bipolar disorder.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Drug Administration Schedule; Drug Costs; Humans; Olanzapine; Piperazines; Practice Guidelines as Topic; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Thiazoles; United States | 2006 |
Maintenance treatment of bipolar disorder: Applying research to clinical practice.
Topics: Anticonvulsants; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Carbamazepine; Evidence-Based Medicine; Humans; Lamotrigine; Lithium Carbonate; Olanzapine; Piperazines; Quinolones; Triazines; Valproic Acid | 2006 |
Aripiprazole: pharmacology and evidence in bipolar disorder.
Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Clinical Trials as Topic; Humans; Piperazines; Quinolones | 2007 |
Maintenance treatment in bipolar disorder: a focus on aripiprazole.
Topics: Antidepressive Agents; Aripiprazole; Bipolar Disorder; Humans; Piperazines; Quinolones; Time | 2007 |
Treatment of bipolar disorder: the evolving role of atypical antipsychotics.
Topics: Antipsychotic Agents; Aripiprazole; Arrhythmias, Cardiac; Benzodiazepines; Bipolar Disorder; Diabetes Mellitus, Type 2; Dibenzothiazepines; Drug Evaluation; Drug Interactions; Drug Therapy, Combination; Dyslipidemias; Humans; Hyperprolactinemia; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Thiazoles; Treatment Outcome; Weight Gain | 2007 |
A review of sensitivity and tolerability of antipsychotics in patients with bipolar disorder or schizophrenia: focus on somnolence.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Double-Blind Method; Haloperidol; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Research Design; Risperidone; Schizophrenia; Sleep Stages; Thiazoles; Treatment Outcome | 2008 |
Intramuscular aripiprazole : a review of its use in the management of agitation in schizophrenia and bipolar I disorder.
Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Humans; Injections, Intramuscular; Piperazines; Psychomotor Agitation; Quinolones; Schizophrenia | 2008 |
47 trial(s) available for carbostyril and Bipolar Disorder
| Article | Year |
|---|---|
Two randomized, double-blind, placebo-controlled trials and one open-label, long-term trial of brexpiprazole for the acute treatment of bipolar mania.
Topics: Adult; Bipolar Disorder; Dopamine Agonists; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Quinolones; Serotonin Agents; Thiophenes; Treatment Outcome | 2021 |
Aripiprazole for the treatment of pediatric bipolar I disorder: a 30-week, randomized, placebo-controlled study.
Topics: Adolescent; Analysis of Variance; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Child; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Piperazines; Psychiatric Status Rating Scales; Quinolones; Treatment Outcome; United States | 2013 |
Clinical significance of treatment effects with aripiprazole versus placebo in a study of manic or mixed episodes associated with pediatric bipolar I disorder.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Child; Female; Humans; Male; Parents; Piperazines; Psychiatric Status Rating Scales; Quinolones; Reproducibility of Results; Severity of Illness Index; Statistics, Nonparametric; Treatment Outcome | 2013 |
Intramuscular aripiprazole in the acute management of psychomotor agitation.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Female; Hospitals, University; Humans; Injections, Intramuscular; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Psychomotor Agitation; Quinolones; Schizophrenia; Time Factors; Treatment Outcome; Young Adult | 2013 |
The ARIQUELI study: potentiation of quetiapine in bipolar I nonresponders with lithium versus aripiprazole.
Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Brazil; Clinical Protocols; Dibenzothiazepines; Drug Synergism; Drug Therapy, Combination; Female; Humans; Lithium Compounds; Male; Piperazines; Psychiatric Status Rating Scales; Quetiapine Fumarate; Quinolones; Research Design; Time Factors; Treatment Outcome; Young Adult | 2013 |
Criteria for defining symptomatic and sustained remission in bipolar I disorder: a post-hoc analysis of a 26-week aripiprazole study (study CN138-010).
Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Double-Blind Method; Female; Humans; Male; Piperazines; Psychiatric Status Rating Scales; Quinolones; Recurrence | 2008 |
Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double-blind, placebo- and lithium-controlled study.
Topics: Acute Disease; Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Female; Follow-Up Studies; Headache; Humans; Lithium Compounds; Male; Middle Aged; Nausea; Piperazines; Placebos; Psychiatric Status Rating Scales; Quinolones; Severity of Illness Index; Treatment Outcome; Weight Gain | 2009 |
Effect of aripiprazole on self-reported anhedonia in bipolar depressed patients.
Topics: Adult; Affect; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Depression; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Personality Inventory; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Psychometrics; Quinolones | 2009 |
Beneficial acute antidepressant effects of aripiprazole as an adjunctive treatment or monotherapy in bipolar patients unresponsive to mood stabilizers: results from a 16-week open-label trial.
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Body Weight; Depression; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Headache; Humans; Lorazepam; Male; Middle Aged; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Quinolones; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Young Adult | 2008 |
Aripiprazole monotherapy in acute mania: 12-week randomised placebo- and haloperidol-controlled study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Double-Blind Method; Endpoint Determination; Female; Haloperidol; Humans; Male; Middle Aged; Piperazines; Quinolones; Treatment Outcome; Young Adult | 2009 |
A non-randomized study to investigate the effects of the atypical antipsychotic aripiprazole on the steady-state pharmacokinetics of lamotrigine in patients with bipolar I disorder.
Topics: Adult; Anticonvulsants; Antipsychotic Agents; Area Under Curve; Aripiprazole; Bipolar Disorder; Dose-Response Relationship, Drug; Drug Interactions; Female; Humans; Lamotrigine; Male; Middle Aged; Piperazines; Quinolones; Sleep Initiation and Maintenance Disorders; Triazines | 2009 |
Aripiprazole prescribing patterns and side effects in elderly psychiatric inpatients.
Topics: Aged; Aged, 80 and over; Aging; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Depressive Disorder, Major; Dose-Response Relationship, Drug; Female; Humans; Inpatients; Male; Mental Disorders; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Psychomotor Agitation; Psychotic Disorders; Quinolones; Retrospective Studies; Schizophrenia; Treatment Outcome | 2009 |
Aripiprazole in children and adolescents with bipolar disorder comorbid with attention-deficit/hyperactivity disorder: a pilot randomized clinical trial.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Child; Comorbidity; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Humans; Pilot Projects; Piperazines; Quinolones; Surveys and Questionnaires | 2009 |
Methylphenidate combined with aripiprazole in children and adolescents with bipolar disorder and attention-deficit/hyperactivity disorder: a randomized crossover trial.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Central Nervous System Stimulants; Child; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Methylphenidate; Piperazines; Psychiatric Status Rating Scales; Quinolones; Severity of Illness Index | 2009 |
Acute treatment of pediatric bipolar I disorder, manic or mixed episode, with aripiprazole: a randomized, double-blind, placebo-controlled study.
Topics: Adolescent; Age Factors; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Child; Child, Preschool; Comorbidity; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Piperazines; Psychiatric Status Rating Scales; Quinolones; Treatment Outcome | 2009 |
Aripiprazole as adjunct to a mood stabilizer and citalopram in bipolar depression: a randomized placebo-controlled pilot study.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Antimanic Agents; Aripiprazole; Bipolar Disorder; Citalopram; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pilot Projects; Piperazines; Quality of Life; Quinolones; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Surveys and Questionnaires | 2010 |
Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study.
Topics: Adult; Antimanic Agents; Aripiprazole; Bipolar Disorder; Drug Therapy, Combination; Female; Humans; Lithium Compounds; Male; Middle Aged; Piperazines; Quinolones; Treatment Outcome; Valproic Acid | 2010 |
Metabolic syndrome in patients enrolled in a clinical trial of aripiprazole in the maintenance treatment of bipolar I disorder: a post hoc analysis of a randomized, double-blind, placebo-controlled trial.
Topics: Adult; Antipsychotic Agents; Argentina; Aripiprazole; Bipolar Disorder; Comorbidity; Cross-Sectional Studies; Double-Blind Method; Female; Humans; Incidence; Long-Term Care; Male; Metabolic Syndrome; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Quinolones | 2010 |
A comparison of two fixed doses of aripiprazole with placebo in acutely relapsed, hospitalized patients with bipolar disorder I (manic or mixed) in subpopulations (CN138-007).
Topics: Acute Disease; Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Hospitalization; Humans; Male; Piperazines; Quinolones; Secondary Prevention; Treatment Outcome | 2010 |
Clinical value of early partial symptomatic improvement in the prediction of response and remission during short-term treatment trials in 3369 subjects with bipolar I or II depression.
Topics: Antidepressive Agents, Second-Generation; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Drug Therapy, Combination; Fluoxetine; Humans; Lamotrigine; Olanzapine; Piperazines; Predictive Value of Tests; Psychiatric Status Rating Scales; Quetiapine Fumarate; Quinolones; Remission Induction; Sensitivity and Specificity; Time Factors; Treatment Outcome; Triazines | 2011 |
Efficacy of aripiprazole adjunctive to lithium or valproate in the long-term treatment of patients with bipolar I disorder with an inadequate response to lithium or valproate monotherapy: a multicenter, double-blind, randomized study.
Topics: Adult; Antimanic Agents; Aripiprazole; Bipolar Disorder; Confidence Intervals; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lithium; Longitudinal Studies; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Quinolones; Time Factors; Treatment Outcome; Valproic Acid | 2011 |
Young mania rating scale line item analysis in pediatric subjects with bipolar I disorder treated with aripiprazole in a short-term, double-blind, randomized study.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Child; Comorbidity; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Inpatients; Male; Outpatients; Piperazines; Placebos; Psychiatric Status Rating Scales; Quinolones; Time Factors; Treatment Outcome | 2011 |
An open-label study of aripiprazole in children with a bipolar disorder.
Topics: Antipsychotic Agents; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Central Nervous System Stimulants; Child; Child, Preschool; Comorbidity; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Male; Outpatients; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Quinolones; Treatment Outcome; Weight Gain | 2011 |
Aripiprazole plus divalproex for recently manic or mixed patients with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind maintenance trial.
Topics: Adult; Aripiprazole; Bipolar Disorder; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Piperazines; Quinolones; Time Factors; Treatment Outcome; Valproic Acid | 2011 |
Double-blind, randomized, placebo-controlled long-term maintenance study of aripiprazole in children with bipolar disorder.
Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Child; Child, Preschool; Double-Blind Method; Female; Humans; Male; Piperazines; Quinolones | 2012 |
A 40-week double-blind aripiprazole versus lithium follow-up of a 12-week acute phase study (total 52 weeks) in bipolar I disorder.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Double-Blind Method; Female; Follow-Up Studies; Humans; Lithium Compounds; Male; Middle Aged; Piperazines; Quinolones; Young Adult | 2012 |
Comparative effectiveness of switching antipsychotic drug treatment to aripiprazole or ziprasidone for improving metabolic profile and atherogenic dyslipidemia: a 12-month, prospective, open-label study.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Atherosclerosis; Bipolar Disorder; Cohort Studies; Diagnostic and Statistical Manual of Mental Disorders; Drug Monitoring; Dyslipidemias; Female; Humans; Intention to Treat Analysis; Male; Middle Aged; North America; Patient Dropouts; Piperazines; Psychotic Disorders; Quinolones; Risk Factors; Schizophrenia; Severity of Illness Index; Thiazoles; Weight Loss | 2012 |
Aripiprazole in combination with lamotrigine for the long-term treatment of patients with bipolar I disorder (manic or mixed): a randomized, multicenter, double-blind study (CN138-392).
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lamotrigine; Male; Middle Aged; Piperazines; Quinolones; Secondary Prevention; Treatment Outcome; Triazines | 2012 |
A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole for the treatment of acute manic or mixed episodes in Asian patients with bipolar I disorder (the AMAZE study).
Topics: Acute Disease; Adult; Antipsychotic Agents; Aripiprazole; Asia; Asian People; Bipolar Disorder; Double-Blind Method; Humans; Middle Aged; Piperazines; Placebos; Psychiatric Status Rating Scales; Quinolones; Treatment Outcome | 2014 |
Respondent and item level patterns of response of aripiprazole in the acute treatment of pediatric bipolar I disorder.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Child; Depression; Double-Blind Method; Female; Humans; Male; Parents; Piperazines; Psychiatric Status Rating Scales; Quinolones; Treatment Outcome | 2012 |
Investigation into the long-term metabolic effects of aripiprazole adjunctive to lithium, valproate, or lamotrigine.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Body Weight; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Lamotrigine; Lithium; Male; Metabolic Syndrome; Middle Aged; Obesity; Overweight; Piperazines; Quinolones; Time Factors; Treatment Outcome; Triazines; Valproic Acid | 2013 |
Efficacy of aripiprazole versus placebo as adjuncts to lithium or valproate in relapse prevention of manic or mixed episodes in bipolar I patients stratified by index manic or mixed episode.
Topics: Adult; Aripiprazole; Bipolar Disorder; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lithium Compounds; Longitudinal Studies; Male; Middle Aged; Piperazines; Quinolones; Secondary Prevention; Single-Blind Method; Tranquilizing Agents; Valproic Acid | 2013 |
A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania.
Topics: Acute Disease; Adult; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Bipolar Disorder; Double-Blind Method; Female; Humans; Male; Piperazines; Placebos; Quinolones; Treatment Outcome | 2003 |
Switching outpatients with bipolar or schizoaffective disorders and substance abuse from their current antipsychotic to aripiprazole.
Topics: Adult; Ambulatory Care; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Comorbidity; Diagnosis, Dual (Psychiatry); Dopamine Agonists; Female; Humans; Male; Pilot Projects; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Quinolones; Receptors, Dopamine D2; Substance-Related Disorders; Treatment Outcome | 2005 |
Effectiveness of aripiprazole v. haloperidol in acute bipolar mania: double-blind, randomised, comparative 12-week trial.
Topics: Acute Disease; Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Body Weight; Double-Blind Method; Electrocardiography; Female; Haloperidol; Humans; Male; Middle Aged; Patient Dropouts; Piperazines; Prolactin; Psychiatric Status Rating Scales; Quinolones; Treatment Outcome | 2005 |
Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Body Weight; Double-Blind Method; Electrocardiography; Female; Humans; Male; Middle Aged; Piperazines; Prolactin; Quinolones | 2006 |
A randomized, double-blind, placebo-controlled 26-week trial of aripiprazole in recently manic patients with bipolar I disorder.
Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Cross-Cultural Comparison; Double-Blind Method; Female; Humans; International Cooperation; Male; Pain; Piperazines; Placebos; Psychiatric Status Rating Scales; Quinolones; Secondary Prevention; Time Factors; Treatment Outcome | 2006 |
Management of acute agitation in patients with bipolar disorder: efficacy and safety of intramuscular aripiprazole.
Topics: Acute Disease; Adult; Anti-Anxiety Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Disorders of Excessive Somnolence; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Headache; Humans; Injections, Intramuscular; Lorazepam; Male; Nausea; Patient Dropouts; Piperazines; Psychomotor Agitation; Quinolones; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Vomiting | 2007 |
Mirtazapine monotherapy versus combination therapy with mirtazapine and aripiprazole in depressed patients without psychotic features: a 4-week open-label parallel-group study.
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Depressive Disorder, Major; Drug Resistance; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Neurologic Examination; Personality Inventory; Piperazines; Quinolones | 2007 |
An open-label trial of aripiprazole monotherapy in children and adolescents with bipolar disorder.
Topics: Adolescent; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Brief Psychiatric Rating Scale; Child; Drug Tolerance; Female; Humans; Male; Piperazines; Quinolones; Surveys and Questionnaires | 2007 |
Efficacy and safety of aripiprazole in subpopulations with acute manic or mixed episodes of bipolar I disorder.
Topics: Acute Disease; Adolescent; Adult; Age Distribution; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Female; Humans; Male; Middle Aged; Piperazines; Placebos; Psychiatric Status Rating Scales; Quinolones; Sleep Initiation and Maintenance Disorders; Treatment Outcome | 2008 |
Aripiprazole in juvenile bipolar disorder comorbid with attention-deficit/hyperactivity disorder: an open clinical trial.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Child; Double-Blind Method; Female; Humans; Male; Piperazines; Quinolones | 2007 |
Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: a 100-week, double-blind study versus placebo.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Depression; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Administration Schedule; Female; GABA Modulators; Humans; Lorazepam; Male; Piperazines; Prevalence; Prospective Studies; Quinolones; Remission Induction; Secondary Prevention; Severity of Illness Index; Surveys and Questionnaires | 2007 |
Aripiprazole monotherapy in nonpsychotic bipolar I depression: results of 2 randomized, placebo-controlled studies.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Depressive Disorder, Major; Double-Blind Method; Drug Administration Schedule; Endpoint Determination; Female; Humans; Male; Middle Aged; Piperazines; Quinolones | 2008 |
A prospective, open-label study of Aripiprazole mono- and adjunctive treatment in acute bipolar depression.
Topics: Acute Disease; Adolescent; Adult; Akathisia, Drug-Induced; Ambulatory Care; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Drug Administration Schedule; Drug Therapy, Combination; Endpoint Determination; Female; Humans; Lorazepam; Male; Middle Aged; Nausea; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Quinolones; Treatment Outcome | 2008 |
Aripiprazole therapy in 20 older adults with bipolar disorder: a 12-week, open-label trial.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Bipolar Disorder; Depressive Disorder; Drug Synergism; Drug Therapy, Combination; Electrocardiography; Female; Humans; Interview, Psychological; Lamotrigine; Lithium Carbonate; Male; Middle Aged; Pilot Projects; Piperazines; Prospective Studies; Quinolones; Triazines; Valproic Acid | 2008 |
Aripiprazole monotherapy in patients with rapid-cycling bipolar I disorder: an analysis from a long-term, double-blind, placebo-controlled study.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Piperazines; Prospective Studies; Quinolones; Treatment Outcome | 2008 |
111 other study(ies) available for carbostyril and Bipolar Disorder
| Article | Year |
|---|---|
Gamma oscillations predict treatment response to aripiprazole in bipolar disorder.
Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Humans; Piperazines; Quinolones; Retrospective Studies; Treatment Outcome | 2021 |
A pilot study of brexpiprazole for bipolar depression.
Topics: Adult; Antidepressive Agents; Bipolar Disorder; Cognition; Depressive Disorder, Major; Female; Humans; Irritable Mood; Male; Middle Aged; Pilot Projects; Psychiatric Status Rating Scales; Quality of Life; Quinolones; Thiophenes; Treatment Outcome; Young Adult | 2019 |
Aripiprazole-associated acute dystonia, akathisia, and parkinsonism in a patient with bipolar I disorder.
Topics: Acute Disease; Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Dystonia; Female; Humans; Parkinsonian Disorders; Piperazines; Quinolones | 2013 |
Treatment of youth with bipolar disorder: long-term versus maintenance.
Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Female; Humans; Male; Piperazines; Quinolones | 2013 |
Safety first.
Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Female; Humans; Male; Piperazines; Quinolones | 2013 |
Effectiveness of a clozapine-aripiprazole combination in Tourette syndrome and bipolar spectrum disorder.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Clozapine; Drug Therapy, Combination; Humans; Male; Piperazines; Quinolones; Tourette Syndrome | 2013 |
Reversal of aripiprazole-induced tardive akathisia by addition of pregabalin.
Topics: Adult; Akathisia, Drug-Induced; Anticonvulsants; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Female; gamma-Aminobutyric Acid; Humans; Piperazines; Pregabalin; Quinolones | 2013 |
An evaluation of inpatient treatment continuation and hospital readmission rates in patients with bipolar disorder treated with aripiprazole or quetiapine.
Topics: Adolescent; Adult; Age Factors; Aged; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Cohort Studies; Dibenzothiazepines; Drug Administration Schedule; Drug Therapy, Combination; Female; Hospitalization; Hospitals, Psychiatric; Humans; Inpatients; Male; Middle Aged; Odds Ratio; Patient Readmission; Piperazines; Quetiapine Fumarate; Quinolones; Retrospective Studies; Valproic Acid; Young Adult | 2013 |
Trends in pharmacotherapy in patients referred to a bipolar specialty clinic, 2000-2011.
Topics: Academic Medical Centers; Adult; Ambulatory Care Facilities; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; California; Dibenzothiazepines; Drug Therapy; Female; Humans; Lamotrigine; Male; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Referral and Consultation; Risperidone; Triazines | 2014 |
Aripiprazole: a new risk factor for pathological gambling? A report of 8 case reports.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Dopamine Agonists; Female; Gambling; Humans; Male; Middle Aged; Piperazines; Quinolones; Risk Factors; Schizophrenia; Young Adult | 2014 |
Reversible dopamine transporter reduction in drug-induced Parkinsonism.
Topics: Aged; Aripiprazole; Bipolar Disorder; Brain; Dopamine Plasma Membrane Transport Proteins; Female; Humans; Lithium Carbonate; Parkinson Disease, Secondary; Piperazines; Quinolones; Radionuclide Imaging | 2014 |
Effect of valproate on the plasma concentrations of aripiprazole in bipolar patients.
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Drug Therapy, Combination; Female; Humans; Male; Piperazines; Quinolones; Retrospective Studies; Valproic Acid; Young Adult | 2014 |
Combination of omega-3 Fatty acids, lithium, and aripiprazole reduces oxidative stress in brain of mice with mania.
Topics: Animals; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Brain; Brain Chemistry; Disease Models, Animal; Fatty Acids, Omega-3; Glutathione; Lithium Compounds; Male; Mice; Oxidative Stress; Oxidoreductases; Piperazines; Quinolones | 2014 |
Aripiprazole for the treatment of a manic patient with clozapine-related colonic obstruction receiving total colectomy.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Clozapine; Colectomy; Humans; Intestinal Obstruction; Male; Piperazines; Quinolones | 2014 |
Suppression of antipsychotic-induced tardive dyskinesia with aripiprazole in an elderly patient with bipolar I disorder.
Topics: Aged; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Dyskinesia, Drug-Induced; Humans; Male; Piperazines; Quinolones; Treatment Outcome | 2014 |
Aripiprazole adjunct treatment in bipolar I or II disorder, depressed state: a 2-year clinical study.
Topics: Adult; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Drug Synergism; Drug Therapy, Combination; Female; Humans; Lithium; Male; Middle Aged; Piperazines; Quinolones; Time Factors; Treatment Outcome; Young Adult | 2015 |
Protein kinase C inhibition rescues manic-like behaviors and hippocampal cell proliferation deficits in the sleep deprivation model of mania.
Topics: Animals; Antidepressive Agents, Second-Generation; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzophenanthridines; Bipolar Disorder; Cell Proliferation; Disease Models, Animal; Fluoxetine; Hippocampus; Lithium Chloride; Male; Piperazines; Prefrontal Cortex; Protein Kinase C; Protein Kinase Inhibitors; Quinolones; Rats, Sprague-Dawley; Sleep Deprivation; Tamoxifen | 2014 |
Switching antipsychotic medication to aripiprazole: position paper by a panel of Italian psychiatrists.
Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Clozapine; Drug Substitution; Humans; Italy; Piperazines; Quinolones; Schizophrenia | 2015 |
[Case of graves' disease with remarkable psychiatric symptoms].
Topics: Adult; Affective Disorders, Psychotic; Antipsychotic Agents; Antithyroid Agents; Aripiprazole; Bipolar Disorder; Delusions; Female; Graves Disease; Hallucinations; Humans; Lithium Compounds; Methimazole; Piperazines; Propranolol; Quinolones; Treatment Outcome | 2015 |
Hiccups Associated with Aripiprazole in an Adolescent with Bipolar Disorder.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Female; Hiccup; Humans; Quinolones; Treatment Outcome | 2016 |
The ABC's of dopamine receptor partial agonists - aripiprazole, brexpiprazole and cariprazine: the 15-min challenge to sort these agents out.
Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Depressive Disorder, Major; Dopamine Agonists; Drug Administration Schedule; Drug Interactions; Humans; Piperazines; Quinolones; Schizophrenia; Thiophenes | 2015 |
Aripiprazole for the Treatment of Antipsychotic-Induced Hyperprolactinemia in an Adolescent Boy.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Humans; Hyperprolactinemia; Male; Prolactin; Quinolones; Schizophrenia | 2016 |
Brexpiprazole reduces hyperactivity, impulsivity, and risk-preference behavior in mice with dopamine transporter knockdown-a model of mania.
Topics: Animals; Behavior, Animal; Bipolar Disorder; Choice Behavior; Disease Models, Animal; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Exploratory Behavior; Female; Gene Knockdown Techniques; Impulsive Behavior; Male; Mice; Mice, Inbred C57BL; Motor Activity; Phenotype; Quinolones; Receptor, Serotonin, 5-HT1A; Risk-Taking; Serotonin Agents; Thiophenes | 2017 |
Varenicline-induced mixed mood and psychotic episode in a patient with a past history of depression.
Topics: Antipsychotic Agents; Aripiprazole; Benzazepines; Bipolar Disorder; Depressive Disorder; Female; Genetic Predisposition to Disease; Humans; Middle Aged; Piperazines; Psychoses, Substance-Induced; Psychotherapy; Quinolones; Quinoxalines; Smoking Cessation; Stress, Psychological; Varenicline | 2008 |
Tolerability and pharmacokinetics of aripiprazole in children and adolescents with psychiatric disorders: an open-label, dose-escalation study.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Child; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Piperazines; Quinolones; Schizophrenia | 2008 |
Aripiprazole joins the family of second-generation mood stabilizers.
Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Humans; Piperazines; Quinolones; Treatment Outcome | 2008 |
Practical guidance for prescribing with aripiprazole in bipolar disorder.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Female; Humans; Male; Piperazines; Quinolones | 2008 |
Aripiprazole-induced orthostatic hypotension and cardiac arrhythmia.
Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Dose-Response Relationship, Drug; Female; Humans; Hypotension, Orthostatic; Middle Aged; Piperazines; Quinolones; Schizophrenia; Tachycardia, Supraventricular | 2008 |
Bipolar drug development: are we getting closer to the real world?
Topics: Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Drug Therapy, Combination; Humans; Lithium Compounds; Patient Dropouts; Piperazines; Quinolones; Randomized Controlled Trials as Topic; Treatment Outcome; Valproic Acid | 2008 |
A UK consensus on the administration of aripiprazole for the treatment of mania.
Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Clinical Trials as Topic; Humans; Piperazines; Practice Guidelines as Topic; Practice Patterns, Physicians'; Quinolones; United Kingdom | 2009 |
Predictors of aripiprazole treatment continuation in hospitalized patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Child; Child, Preschool; Cohort Studies; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Hospitalization; Humans; Length of Stay; Male; Middle Aged; Patient Discharge; Piperazines; Psychotic Disorders; Quinolones; Retrospective Studies; Treatment Outcome | 2008 |
Aripiprazole-induced sialorrhea.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Depressive Disorder; Humans; Male; Piperazines; Quinolones; Sialorrhea; Valproic Acid | 2009 |
Refractory restless legs syndrome likely caused by olanzapine.
Topics: Anticonvulsants; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Drug Therapy, Combination; Female; Humans; Middle Aged; Olanzapine; Piperazines; Quinolones; Restless Legs Syndrome; Valproic Acid | 2009 |
Multiple sclerosis presenting with erotomanic delusions in the context of "Don't ask, don't tell".
Topics: Adjuvants, Immunologic; Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Erotica; Female; Humans; Interferon beta-1a; Interferon-beta; Magnetic Resonance Imaging; Military Personnel; Military Psychiatry; Multiple Sclerosis; Organizational Policy; Piperazines; Quinolones; Recognition, Psychology; Schizophrenia, Paranoid; Sex Offenses; Sexual Harassment; Stress, Psychological; Syndrome | 2009 |
Maintenance treatment received by patients with bipolar I and II disorders--a naturalistic prospective study.
Topics: Adult; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Carbamazepine; Cohort Studies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Lamotrigine; Lithium Carbonate; Long-Term Care; Male; Middle Aged; Olanzapine; Oxcarbazepine; Piperazines; Prospective Studies; Quinolones; Risperidone; Triazines; Valproic Acid | 2010 |
Healthcare costs associated with treatment of bipolar disorder using a mood stabilizer plus adjunctive aripiprazole, quetiapine, risperidone, olanzapine or ziprasidone.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Costs and Cost Analysis; Dibenzothiazepines; Drug Therapy, Combination; Female; Health Care Costs; Humans; Male; Middle Aged; Mood Disorders; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Retrospective Studies; Risperidone; Thiazoles; Treatment Outcome; Young Adult | 2009 |
Aripiprazole: new indication. Treatment and prevention of manic episodes: just another neuroleptic.
Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Clinical Trials as Topic; Drug Approval; Europe; Humans; Piperazines; Quinolones | 2009 |
Waxing-and-waning catatonia after intermittent exposure to aripiprazole in a case of autism and bipolar disorder.
Topics: Adult; Aripiprazole; Autistic Disorder; Bipolar Disorder; Catatonia; Humans; Male; Piperazines; Quinolones | 2009 |
Life events, medical comorbidity, and somatic symptoms in pediatric mood disorders.
Topics: Adolescent; Age Factors; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Child; Comorbidity; Female; Humans; Hungary; Life Change Events; Male; Mood Disorders; Piperazines; Quinolones; Randomized Controlled Trials as Topic; Somatoform Disorders; United States | 2009 |
Antipsychotic prescribing practices following withdrawal of concomitant carbamazepine.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Carbamazepine; Cytochrome P-450 Enzyme System; Dibenzothiazepines; Drug Interactions; Drug Therapy, Combination; Enzyme Induction; Female; Humans; Male; Medical Audit; Middle Aged; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Retrospective Studies; Risk Factors; Risperidone | 2009 |
Pediatric bipolar disorder.
Topics: Adolescent; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Child; Child Psychiatry; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Diagnostic and Statistical Manual of Mental Disorders; Humans; Lithium Carbonate; Nursing Assessment; Parents; Patient Education as Topic; Piperazines; Psychiatric Nursing; Psychotherapy; Quinolones; Risperidone; Social Support | 2009 |
Efficacy of the atypical antipsychotic aripiprazole in d-amphetamine-based preclinical models of mania.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Central Nervous System Stimulants; Dextroamphetamine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Locomotion; Male; Piperazines; Quinolones; Rats; Rats, Sprague-Dawley; Self Stimulation | 2010 |
Aripiprazole induced acute dystonia after discontinuation of a stimulant medication.
Topics: Acute Disease; Antipsychotic Agents; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Central Nervous System Stimulants; Child; Drug Administration Schedule; Dystonia; Humans; Male; Methylphenidate; Piperazines; Quinolones; Substance Withdrawal Syndrome | 2010 |
Treatment with aripiprazole for hyperprolactinemia induced by pituitary microadenoma in a bipolar I disorder patient.
Topics: Adenoma; Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Dopamine Antagonists; Female; Humans; Hyperprolactinemia; Piperazines; Pituitary Neoplasms; Quinolones | 2010 |
Symptomatic bradycardia with oral aripiprazole and oral ziprasidone.
Topics: Adolescent; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Bradycardia; Delusions; Electrocardiography; Female; Humans; Lithium Carbonate; Piperazines; Psychotic Disorders; Quinolones; Thiazoles | 2010 |
Potential control of antipsychotic-induced hyperprolactinemia and obesity in children and adolescents by aripiprazole.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Child; Humans; Hyperprolactinemia; Obesity; Piperazines; Quinolones; Schizophrenia | 2010 |
[Long-term (prophylactic) therapy of bipolar patients with aripiprazole].
Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Female; Humans; Middle Aged; Piperazines; Quinolones; Treatment Outcome | 2010 |
Cost effectiveness of adjunctive quetiapine fumarate extended-release tablets with mood stabilizers in the maintenance treatment of bipolar I disorder.
Topics: Absenteeism; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Cost-Benefit Analysis; Delayed-Action Preparations; Dibenzothiazepines; Drug Therapy, Combination; Fees, Pharmaceutical; Health Care Costs; Hospital Charges; Humans; Lamotrigine; Lithium Compounds; Markov Chains; Models, Economic; Olanzapine; Piperazines; Quality-Adjusted Life Years; Quetiapine Fumarate; Quinolones; Risk; Tablets; Triazines; United States; Valproic Acid | 2010 |
Metabolic syndrome and its potential effect on treatment response to aripiprazole: a post hoc analysis of the stabilization phase of a long-term, double-blind study in patients with bipolar disorder (CN138-010).
Topics: Aripiprazole; Bipolar Disorder; Double-Blind Method; Humans; Metabolic Syndrome; Piperazines; Quinolones; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome | 2010 |
Epidemiologic study of aripiprazole use and the incidence of suicide events.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Databases, Factual; Female; Humans; Incidence; Male; Middle Aged; Piperazines; Quinolones; Risk; Schizophrenia; Suicide; Suicide, Attempted; Young Adult | 2010 |
Three cases of hypomania and one case of mania during aripiprazole treatment.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Depressive Disorder, Major; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Piperazines; Quinolones; Young Adult | 2011 |
Aripiprazole-associated bruxism, akathisia, and parkinsonism in a bipolar patient.
Topics: Akathisia, Drug-Induced; Aripiprazole; Bipolar Disorder; Bruxism; Female; Humans; Parkinson Disease, Secondary; Piperazines; Quinolones; Young Adult | 2011 |
Risk of arrest in persons with schizophrenia and bipolar disorder in a Florida Medicaid program: the role of atypical antipsychotics, conventional neuroleptics, and routine outpatient behavioral health services.
Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Clozapine; Crime; Delayed-Action Preparations; Dibenzothiazepines; Female; Florida; Humans; Isoxazoles; Male; Medicaid; Middle Aged; Olanzapine; Outpatients; Paliperidone Palmitate; Piperazines; Propensity Score; Pyrimidines; Quetiapine Fumarate; Quinolones; Risk Factors; Risperidone; Schizophrenia; Treatment Outcome; United States; Young Adult | 2011 |
[Aripiprazole-induced parkinsonism in a 64-year-old female patient diagnosed with bipolar disorder].
Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Female; Humans; Middle Aged; Parkinson Disease; Piperazines; Quinolones | 2011 |
Metabolic effects and cost-effectiveness of aripiprazole versus olanzapine in schizophrenia and bipolar disorder.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Coronary Disease; Costs and Cost Analysis; Female; Humans; Male; Metabolic Diseases; Metabolism; Middle Aged; Olanzapine; Piperazines; Quality-Adjusted Life Years; Quinolones; Risk Assessment; Schizophrenia; Sweden | 2011 |
Safety of antipsychotics in the setting of QTc prolongation: the utility of the JT index.
Topics: Aged; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Bundle-Branch Block; Combined Modality Therapy; Cooperative Behavior; Electrocardiography; Electroconvulsive Therapy; Female; Haloperidol; Humans; Interdisciplinary Communication; Long QT Syndrome; Piperazines; Quinolones; Risk Factors; Torsades de Pointes | 2011 |
Confounding by indication of a specific antipsychotic and the increase of body mass index among children and adolescents.
Topics: Adolescent; Analysis of Variance; Antipsychotic Agents; Aripiprazole; Attention Deficit and Disruptive Behavior Disorders; Benzodiazepines; Bipolar Disorder; Body Mass Index; Body Weight; Child; Dibenzothiazepines; Female; Follow-Up Studies; Humans; Male; Mental Disorders; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Spain; Time Factors | 2011 |
Manic induction with interferon alpha therapy.
Topics: Adult; Antipsychotic Agents; Antiviral Agents; Aripiprazole; Bipolar Disorder; Hepatitis C; Humans; Interferon-alpha; Male; Piperazines; Quinolones; Schizophrenia | 2011 |
Aripiprazole augmentation treatment in treatment resistant bipolar depression: two patient reports.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Depressive Disorder, Treatment-Resistant; Drug Administration Schedule; Female; Humans; Piperazines; Psychiatric Status Rating Scales; Quinolones | 2011 |
Neurocognitive effects of aripiprazole in adolescents and young adults with bipolar disorder.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Brief Psychiatric Rating Scale; Cognition; Cognition Disorders; Diagnostic and Statistical Manual of Mental Disorders; Female; Humans; Male; Piperazines; Prospective Studies; Quinolones; Severity of Illness Index; Taiwan; Young Adult | 2012 |
Intermittent aripiprazole for schizophrenia.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Quinolones; Retrospective Studies; Schizophrenia | 2012 |
Efficacy of aripiprazole in comorbid addiction in bipolar disorder.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Humans; Male; Piperazines; Quinolones; Substance-Related Disorders; Treatment Outcome | 2012 |
Impulse control loss rapidly reversed by aripiprazole in a patient with concomitant bipolar disease type I and posttraumatic frontal lobe lesions.
Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Brain Injuries; Disruptive, Impulse Control, and Conduct Disorders; Humans; Male; Middle Aged; Piperazines; Quinolones | 2011 |
Improvement in intractable tardive dystonia in bipolar disorder after aripiprazole treatment: a case report.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Drug Resistance; Humans; Male; Movement Disorders; Piperazines; Quinolones | 2012 |
A UK panel consensus on the initiation of aripiprazole for the treatment of bipolar mania.
Topics: Acute Disease; Anhedonia; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Drug Administration Schedule; Drug Therapy, Combination; Humans; Long-Term Care; Metabolic Diseases; Patient Participation; Piperazines; Psychomotor Agitation; Quinolones; Randomized Controlled Trials as Topic; Recovery of Function; Sexual Dysfunction, Physiological; Treatment Outcome | 2012 |
Graves' hyperthyroidism-induced psychosis treated with aripiprazole--a case report.
Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Female; Graves Disease; Humans; Middle Aged; Piperazines; Psychotic Disorders; Quinolones | 2013 |
Medication adherence and utilization in patients with schizophrenia or bipolar disorder receiving aripiprazole, quetiapine, or ziprasidone at hospital discharge: a retrospective cohort study.
Topics: Adult; Aged; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Databases, Factual; Dibenzothiazepines; Female; Humans; Male; Medication Adherence; Patient Discharge; Piperazines; Quetiapine Fumarate; Quinolones; Retrospective Studies; Schizophrenia; Thiazoles | 2012 |
Heterogeneity in aripiprazole diffusion for bipolar disorder treatment in the Veterans Health Administration.
Topics: Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Cross-Sectional Studies; Diffusion of Innovation; Female; Humans; Male; Middle Aged; Piperazines; Quinolones; Registries; United States; United States Department of Veterans Affairs; United States Food and Drug Administration | 2012 |
Hypomania associated with adjunctive aripiprazole in an elder female with recurrent major depressive disorder: dose-related phenomenon?
Topics: Aripiprazole; Bipolar Disorder; Clonazepam; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluoxetine; Humans; Middle Aged; Piperazines; Quinolones; Recurrence | 2012 |
Rhabdomyolysis in a patient on aripiprazole with traumatic hip prosthesis luxation.
Topics: Aged, 80 and over; Antipsychotic Agents; Aripiprazole; Arthroplasty, Replacement, Hip; Bipolar Disorder; Female; Hip Prosthesis; Humans; Piperazines; Prosthesis Failure; Quinolones; Rhabdomyolysis | 2012 |
Consensus statement on the use of intramuscular aripiprazole for the rapid control of agitation in bipolar mania and schizophrenia.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Haloperidol; Humans; Hypnotics and Sedatives; Olanzapine; Piperazines; Psychomotor Agitation; Quinolones; Schizophrenia; Tranquilizing Agents | 2013 |
Neural correlates of treatment response in depressed bipolar adolescents during emotion processing.
Topics: Adolescent; Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Brain; Citalopram; Depressive Disorder; Dibenzothiazepines; Drug Therapy, Combination; Emotions; Facial Expression; Female; Humans; Lamotrigine; Magnetic Resonance Imaging; Male; Piperazines; Psychotropic Drugs; Quetiapine Fumarate; Quinolones; Sertraline; Triazines; Valproic Acid | 2013 |
Possible increased efficacy of low-dose clozapine when combined with aripiprazole.
Topics: Adult; Aged; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Clozapine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Male; Piperazines; Psychotic Disorders; Quinolones; Schizophrenia, Paranoid; Treatment Outcome | 2004 |
The risk of harm in mania and the very early time course of improvement: important but neglected variables in treatment research.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Humans; Olanzapine; Piperazines; Quality of Life; Quinolones; Risk Factors; Self-Injurious Behavior; Thiazoles | 2004 |
Aripiprazole for acute bipolar mania.
Topics: Acute Disease; Analysis of Variance; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Humans; Multicenter Studies as Topic; Piperazines; Placebos; Psychiatric Status Rating Scales; Quinolones; Randomized Controlled Trials as Topic; Reproducibility of Results; Research Design; Treatment Outcome | 2004 |
Aripiprazole in the treatment of bipolar disorder in children and adolescents.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Humans; Male; Piperazines; Quinolones | 2004 |
The effectiveness and tolerability of aripiprazole for pediatric bipolar disorders: a retrospective chart review.
Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Child; Child, Preschool; Female; Humans; Male; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Quinolones; Retrospective Studies; Treatment Outcome | 2004 |
Aripiprazole in the treatment of pediatric bipolar disorder: a systematic chart review.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Male; Piperazines; Quinolones; Treatment Outcome | 2005 |
Aripiprazole and depression in schizoaffective disorder.
Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Comorbidity; Humans; Male; Middle Aged; Piperazines; Psychotic Disorders; Quinolones; Treatment Outcome | 2005 |
Improvement in tardive dyskinesia with aripiprazole use.
Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Drug Interactions; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Long-Term Care; Middle Aged; Piperazines; Quinolones; Risperidone; Valproic Acid | 2005 |
TrkB partial agonists: potential treatment strategy for epilepsy, mania, and autism.
Topics: Aripiprazole; Autistic Disorder; Bipolar Disorder; Brain-Derived Neurotrophic Factor; Epilepsy; Humans; Piperazines; Quinolones; Receptor, trkB; Signal Transduction | 2006 |
Aripiprazole: initial clinical experience with 142 hospitalized psychiatric patients.
Topics: Adult; Aged; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Body Weight; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Hospitalization; Humans; Male; Mathematical Computing; Middle Aged; Obesity; Piperazines; Product Surveillance, Postmarketing; Psychotic Disorders; Quinolones; Receptors, Dopamine D2; Schizophrenia; Treatment Outcome | 2005 |
Aripiprazole in children and adolescents: clinical experience.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Attention Deficit and Disruptive Behavior Disorders; Bipolar Disorder; Child; Child Behavior Disorders; Child, Preschool; Dose-Response Relationship, Drug; Female; Humans; Male; Piperazines; Prospective Studies; Quinolones; Retrospective Studies; Treatment Outcome; Treatment Refusal | 2005 |
Treatment of withdrawal dyskinesia.
Topics: Adolescent; Amino Acids, Branched-Chain; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Humans; Male; Neurologic Examination; Piperazines; Quinolones; Substance Withdrawal Syndrome; Treatment Outcome | 2005 |
Is there a real difference between the first onset of efficacy for atypical antipsychotic monotherapies in acute bipolar mania?
Topics: Acute Disease; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Clinical Trials as Topic; Humans; Outcome Assessment, Health Care; Piperazines; Psychiatric Status Rating Scales; Quinolones; Research Design; Risperidone; Sensitivity and Specificity; Time Factors; Treatment Outcome | 2005 |
Treatment-emergent psychosis with aripiprazole.
Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Female; Humans; Middle Aged; Piperazines; Psychoses, Substance-Induced; Psychotic Disorders; Quinolones | 2005 |
Priapism associated with oxcarbazepine, aripiprazole, and lithium.
Topics: Adolescent; Affective Symptoms; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Carbamazepine; Child; Child Development Disorders, Pervasive; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Humans; Lithium Carbonate; Male; Oxcarbazepine; Penile Erection; Piperazines; Priapism; Quinolones | 2005 |
Aripiprazole-induced movement disorder.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Bipolar Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Dyskinesia, Drug-Induced; Female; Humans; Piperazines; Quinolones; Syndrome | 2006 |
Improvement or worsening of psychotic symptoms after treatment with low doses of aripiprazole.
Topics: Adult; Aged; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Dopamine Agonists; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Piperazines; Psychoses, Substance-Induced; Psychotic Disorders; Quinolones; Schizophrenia; Serotonin Agents; Treatment Outcome | 2007 |
Aripiprazole-induced acute dystonia.
Topics: Acute Disease; Adolescent; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Dystonia; Humans; Male; Muscarinic Antagonists; Piperazines; Quinolones; Torticollis; Trihexyphenidyl | 2006 |
Questionable advertising of psychotropic medications and disease mongering.
Topics: Advertising; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Drug Industry; Humans; Piperazines; Psychotropic Drugs; Quinolones | 2006 |
Neuroleptic malignant syndrome with aripiprazole and lithium: a case report.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Humans; Lithium; Male; Neuroleptic Malignant Syndrome; Piperazines; Quinolones | 2006 |
Advanced pediatric psychopharmacology.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Cannabinoids; Combined Modality Therapy; Comorbidity; Drug Therapy, Combination; Humans; Male; Marijuana Abuse; Mental Status Schedule; Neuroleptic Malignant Syndrome; Patient Readmission; Piperazines; Prognosis; Psychoses, Substance-Induced; Quinolones; Recurrence; Social Environment; Thiazoles; Treatment Refusal | 2006 |
Does antipsychotic polypharmacy increase the risk for metabolic syndrome?
Topics: Adult; Age Factors; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Body Mass Index; Cholesterol, HDL; Clozapine; Cross-Sectional Studies; Dibenzothiazepines; Drug Therapy, Combination; Female; Humans; Insulin Resistance; Male; Metabolic Syndrome; Middle Aged; Piperazines; Quetiapine Fumarate; Quinolones; Risk Factors; Schizophrenia; Thiazoles; Triglycerides | 2007 |
Adjunctive aripiprazole in bipolar I depression.
Topics: Adult; Aged, 80 and over; Aripiprazole; Bipolar Disorder; Female; Humans; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Quinolones; Retrospective Studies | 2007 |
Manic episode during treatment with aripiprazole.
Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Female; Humans; Middle Aged; Piperazines; Psychotic Disorders; Quinolones | 2007 |
Open-label aripiprazole in the treatment of acute bipolar depression: a prospective pilot trial.
Topics: Acute Disease; Adult; Akathisia, Drug-Induced; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Body Weight; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Patient Dropouts; Pilot Projects; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Quinolones | 2007 |
Aripiprazole augmentation in treatment-resistant bipolar depression: early response and development of akathisia.
Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Drug Synergism; Female; Humans; Male; Middle Aged; Piperazines; Quinolones | 2007 |
Acute dystonia associated with aripiprazole in a child.
Topics: Acute Disease; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Child; Dystonia; Humans; Male; Piperazines; Quinolones; Receptors, Dopamine D2 | 2007 |
A case of aripiprazole-induced mania.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Dibenzothiazepines; Humans; Male; Mood Disorders; Piperazines; Quetiapine Fumarate; Quinolones; Schizophrenia, Paranoid | 2007 |
Aripiprazole-induced hyponatremia: a case report.
Topics: Aged; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Humans; Hyponatremia; Male; Piperazines; Quinolones | 2007 |
Aripiprazole augmentation for treatment-resistant bipolar depression: sustained remission after 36 months.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Piperazines; Prospective Studies; Quinolones; Treatment Outcome | 2007 |
Intramuscular aripiprazole in the control of agitation.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Arousal; Bipolar Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Haloperidol; Humans; Hypnotics and Sedatives; Injections, Intramuscular; Lorazepam; Male; Middle Aged; Multicenter Studies as Topic; Piperazines; Psychiatric Status Rating Scales; Psychomotor Agitation; Quinolones; Randomized Controlled Trials as Topic; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2007 |
Aripiprazole in a patient susceptible to urinary side effects of antipsychotics.
Topics: Adult; Anticonvulsants; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Carbamazepine; Drug Therapy, Combination; Humans; Male; Piperazines; Quinolones; Urinary Retention | 2007 |
Paradoxical motor syndrome following a switch from atypical neuroleptics to aripiprazole.
Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Dopamine D2 Receptor Antagonists; Female; Humans; Middle Aged; Parkinsonian Disorders; Piperazines; Quinolones; Receptors, Dopamine D2 | 2007 |
Resolution of haloperidol-induced hyperprolactinemia with aripiprazole.
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Clonazepam; Dose-Response Relationship, Drug; Drug Therapy, Combination; Gynecomastia; Haloperidol; Humans; Hyperprolactinemia; Male; Piperazines; Prolactin; Quinolones; Valproic Acid | 2007 |
Antimanic response to aripiprazole in bipolar I disorder patients is independent of the agitation level at baseline.
Topics: Antimanic Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Data Interpretation, Statistical; Diagnostic and Statistical Manual of Mental Disorders; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Piperazines; Psychomotor Agitation; Quinolones; Severity of Illness Index; Surveys and Questionnaires | 2007 |
Practical strategies for assessing and stabilizing bipolar patients in urgent situations.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Emergency Services, Psychiatric; Humans; Impulsive Behavior; Injections, Intramuscular; Olanzapine; Piperazines; Practice Guidelines as Topic; Quinolones; Risperidone; Suicide, Attempted; Thiazoles; Time Factors | 2007 |
Photo-onycholysis caused by olanzapine and aripiprazole.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Erythema; Female; Humans; Middle Aged; Olanzapine; Onycholysis; Photosensitivity Disorders; Piperazines; Quinolones | 2008 |
Aripiprazole efficacy in irritability and disruptive-aggressive symptoms: young mania rating scale line analysis from two, randomized, double-blind, placebo-controlled trials.
Topics: Affective Symptoms; Aggression; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Conduct Disorder; Double-Blind Method; Humans; Irritable Mood; Mood Disorders; Multicenter Studies as Topic; Piperazines; Psychiatric Status Rating Scales; Quinolones; Randomized Controlled Trials as Topic; Treatment Outcome | 2008 |
Delayed presentation of an aripiprazole overdose.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Disorders of Excessive Somnolence; Drug Overdose; Female; Half-Life; Humans; Piperazines; Quinolones; Suicide, Attempted; Time Factors | 2008 |